NWSA vs SLS · rev $9.03B vs $1.62B cap
NWSA (NWSA) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
NWSA currently screens at market cap $0. SLS currently screens at market cap $1.62B.
Not investment advice. Open the NWSA and SLS stock pages for the full models.
Not investment advice.